title: Does the persistently normal aminotransferase levels in hepatitis C still have relevance?
authors.forename: Jorge
authors.initials: J
authors.lastname: Méndez-Navarro
authors.forename: Margarita
authors.initials: M
authors.lastname: Dehesa-Violante
mesh_terms: D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D005260:Female; D005838:Genotype; D019698:Hepatitis C, Chronic / Q000097:blood* / Q000188:drug therapy* / Q000208:ethnology; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000627:therapeutic use; D011446:Prospective Studies; D011994:Recombinant Proteins / Q000627:therapeutic use; D012189:Retrospective Studies; D012254:Ribavirin / Q000627:therapeutic use; D000637:Transaminases / Q000097:blood*; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D015415:Biomarkers; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; D000637:Transaminases; C100416:peginterferon alfa-2a